CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Capital in Excess of Par Value	Capital in Excess of Par Value Cumulative Effect, Period of Adoption, Adjustment	Capital in Excess of Par Value Cumulative Effect, Period of Adoption, Adjusted Balance	Equity Consideration Payable	Equity Consideration Payable Cumulative Effect, Period of Adoption, Adjusted Balance	(Accumulated Deficit) Retained Earnings	(Accumulated Deficit) Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	(Accumulated Deficit) Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Cumulative Effect, Period of Adoption, Adjusted Balance	Treasury Stock	Treasury Stock Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2021				28,094,000	28,094,000
Beginning balance at Dec. 31, 2021	$ 504,345	$ (80,036)	$ 424,309	$ 562	$ 562	$ 640,937	$ (66,656)	$ 574,281	$ 0	$ 0	$ (122,505)	$ (13,380)	$ (135,885)	$ (3,704)	$ (3,704)	$ (10,945)	$ (10,945)
Treasury stock (in shares) at Dec. 31, 2021																1,181,000	1,181,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of stock options (in shares)				133,000
Issuance of common stock upon the exercise of stock options	1,286			$ 3		1,283
Net issuance of restricted stock awards (in shares)				200,000
Net issuance of restricted stock awards	1			$ 2		(1)
Issuance of restricted stock for acquisition (in shares)				163,000
Issuance of restricted stock for acquisition	6,300			$ 3		6,297
Treasury stock acquired from employees upon exercise of stock options (in shares)																90,000
Treasury stock acquired from employees upon exercise of stock options	(3,148)															$ (3,148)
Stock-based compensation	13,426					13,426
Foreign currency translation adjustments	2,339													2,339
Net loss	(69,319)										(69,319)
Ending balance (in shares) at Dec. 31, 2022				28,590,000
Ending balance at Dec. 31, 2022	375,194			$ 570		595,286			0		(205,204)			(1,365)		$ (14,093)
Treasury stock (in shares) at Dec. 31, 2022																1,271,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of stock options (in shares)				96,000
Issuance of common stock upon the exercise of stock options	1,069			$ 2		1,067
Net issuance of restricted stock awards (in shares)				203,000
Net issuance of restricted stock awards	2			$ 2
Issuance of common stock for conversion of Notes (in shares)				497,000
Issuance of common stock for conversion of Notes	14,384			$ 10		14,374
Treasury stock acquired from employees upon exercise of stock options (in shares)																85,000
Treasury stock acquired from employees upon exercise of stock options	(2,685)															$ (2,685)
Stock-based compensation	14,427					14,427
Foreign currency translation adjustments	426													426
Net loss	$ (69,752)										(69,752)
Ending balance (in shares) at Dec. 31, 2023	28,029,915			29,386,000
Ending balance at Dec. 31, 2023	$ 333,065			$ 584		625,154			0		(274,956)			(939)		$ (16,778)
Treasury stock (in shares) at Dec. 31, 2023	1,356,319															1,356,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of stock options (in shares)	188,000			190,000
Issuance of common stock upon the exercise of stock options	$ 2,235			$ 4		2,231
Net issuance of restricted stock awards (in shares)				422,000
Net issuance of restricted stock awards	0			$ 6		(6)
Issuance of restricted stock for acquisition (in shares)				2,605,000
Issuance of restricted stock for acquisition	133,180			$ 52		133,128
Equity consideration payable for acquisition	108,182								108,182
Issuance of common stock for conversion of Notes (in shares)				2,382,000
Issuance of common stock for conversion of Notes	104,148			$ 47		104,101
Treasury stock acquired from employees upon exercise of stock options (in shares)																114,000
Treasury stock acquired from employees upon exercise of stock options	(5,071)															$ (5,071)
Issuance of common stock for employee stock purchase plan (in shares)				28,000
Issuance of common stock for employee stock purchase plan	989			$ 1		988
Payments for common stock issuance costs	5,500
Proceeds from public share offering, net of issuance costs (in shares)				5,175,000
Proceeds from private placement of common stock, net of issuance costs of $5.5 million	194,490			$ 104		194,386
Stock-based compensation	25,491					25,491
Foreign currency translation adjustments	(20,012)													(20,012)
Net loss	$ (4,987)										(4,987)
Ending balance (in shares) at Dec. 31, 2024	38,717,366			40,188,000
Ending balance at Dec. 31, 2024	$ 871,710			$ 798		$ 1,085,473			$ 108,182		$ (279,943)			$ (20,951)		$ (21,849)
Treasury stock (in shares) at Dec. 31, 2024	1,470,305															1,470,000